PTK2 and lung cancer: Previous studies have shown that vimentin regulates cell-ECM association by controlling the size of focal adhesions through interacting with integrin β1 and β3 [69], vimentin also increases lung cancer cell adhesion by stabilising FAK-positive focal adhesions through activating Rac1 [70].